Fundrise Innovation Fund LLC Common Shares of Limited Liability Company Interests (VCX)
Key Financials
| Current Price | $24.92 |
| Market Cap | — |
| P/E Ratio | — |
| ROE | —% |
| Dividend Yield | 0% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I approach this as a Graham-style exercise in what can be known, and here the answer is not much. The security is a common-share interest in Fundrise Innovation Fund LLC, an asset-management vehicle that directly invests in middle-, late-, and growth-stage technology businesses. The price is $24.38 at the close on 2026-10-16. That is near the low end of a 52-week range of $23.18 to $575.00, but a wide range alone tells me about volatility and past marks, not intrinsic value. The supplied data show no market cap, P/E, P/B, EPS, ROE, ROCE, debt-to-equity, revenue growth, or profit growth; all are N/A. There are zero years of filed annual results, so the computed Lynch category is none because at least three years are needed. The dividend yield is 0.00%. As a venture fund, value ultimately depends on portfolio marks, cash flows, exits, fees, and dilution, none of which are in the filed figures here. Without those, I cannot assess business quality, a competitive moat, financial health, or growth trajectory. Graham would insist on defensible numbers and a margin of safety; Buffett would stay inside a circle of competence. With price at $24.38 and no audited multi-year record, the honest conclusion is that the price may be low versus its own range, but cheapness versus intrinsic value is unproven. I would want portfolio-level NAV, audited financials, and cash-flow detail before calling this anything more than speculative.
In plain English: This is a private technology investment fund that directly invests in growth-stage companies across areas such as AI, data, fintech, biotech, and health tech. The available data show no revenue, profit, asset values, debt, or multi-year track record, so it is hard to tell whether the business is strong or weak. At $24.38, the price is near the bottom of its 52-week range of $23.18 to $575.00, but without earnings or asset values there is no reliable way to call it cheap, fair, or expensive.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-16 close · note generated 2026-10-20 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer